Procedure:   tail suspension test          


    Access protocols via the Procedure column.
Data set MPD ID Procedure / Protocol Drug or Challenge Phenotype Measure Panel No. of Strains Sex Age Sample Size (Avg) Year
    Chesler4 47026 tail suspension test (none) average frequency climbing, 5 min test   [n]  TS_frequency_climbing DO population w/CC8 9 both 12-16wks N=8 2013
    Chesler4 47027 tail suspension test (none) average time immobile, 5 min test   [s]  TS_time_immobile DO population w/CC8 9 both 12-16wks N=8 2013
    Chesler4 47028 tail suspension test (none) average latency to first immobility episode, 5 min test   [s]  TS_latency_immobile DO population w/CC8 9 both 12-16wks N=8 2013
    Gershenfeld1 16201 tail suspension test (none) TST duration of immobility, effect of saline injection on control group   [s]     before injection    after injection inbred 12 m 5-10wks N=5 2003
    Gershenfeld1 16203 tail suspension test imipramine TST duration of immobility, treatment group   [s]     baseline    imipramine 30mg/kg inbred 12 m 5-10wks N=5 2003
    Gershenfeld1 16205 tail suspension test imipramine TST immobility percentage, imipramine vs. saline   [%]  TST_immobility_pct inbred 12 m 5-10wks N=5 2003
    Pletcher1 36001 tail suspension test (none) TST immobility percentage   [%]  TST inbred 30 m 7-10wks* N=16 2007
    Schalkwyk1 34531 tail suspension test (none) TST duration of immobility   [s]     trial 1    trial 2 inbred 8 m 9-11wks N=10 2010
    Wiltshire2 38001 tail suspension test fluoxetine TST duration of immobility   [%]     control    fluoxetine inbred 30 m 9-10wks N=10 2011
    All boxes